{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:53:58Z","timestamp":1782276838657,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3-4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.2119\/2007-00094.vanvickle","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T17:36:49Z","timestamp":1554485809000},"page":"184-194","source":"Crossref","is-referenced-by-count":19,"title":["Presenilin-1 280Glu\u2192Ala Mutation Alters C-Terminal APP Processing Yielding Longer A\u03b2 Peptides: Implications for Alzheimer\u2019s Disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Gregory D.","family":"Van Vickle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chera L.","family":"Esh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler A.","family":"Kokjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lyle","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Kalback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean C.","family":"Luehrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Newel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino","family":"Ghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex E.","family":"Roher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"14030184_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","volume":"88","author":"R Brookmeyer","year":"1998","unstructured":"Brookmeyer R, Gray S, and Kawas C. (1998) Projections of Alzheimer\u2019s disease in the United States and the public health impact of delaying disease onset, Am. J. Public Health. 88:1337\u201342.","journal-title":"Am. J. Public Health."},{"key":"14030184_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2990.1987.tb00174.x","volume":"13","author":"EG Gray","year":"1987","unstructured":"Gray EG, Paula-Barbosa M, and Roher A. (1987) Alzheimer\u2019s disease: paired helical filaments and cytomembranes, Neuropathol. Appl. Neurobiol. 13:91\u2013110.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"14030184_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1046\/j.1471-4159.1996.67020723.x","volume":"67","author":"WJ Goux","year":"1996","unstructured":"Goux WJ, Rodriguez S, and Sparkman DR. (1996) Characterization of the glycolipid associated with Alzheimer paired helical filaments. J. Neurochem. 67:723\u201333.","journal-title":"J. Neurochem."},{"key":"14030184_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JAD-2001-3504","volume":"3","author":"WJ Goux","year":"2001","unstructured":"Goux WJ, Liu B, Shumburo AM, Parikh S, and Sparkman DR. (2001) A quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer\u2019s diseased brain. J. Alzheimers Dis. 3:455\u201366.","journal-title":"J. Alzheimers Dis."},{"key":"14030184_CR5","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1073\/pnas.1037392100","volume":"100","author":"WT Kimberly","year":"2003","unstructured":"Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, and Selkoe DJ. (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. U. S. A. 100:6382\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"14030184_CR6","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1021\/bi060799c","volume":"45","author":"MS Wolfe","year":"2006","unstructured":"Wolfe MS. (2006) The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry. 45:7931\u20139.","journal-title":"Biochemistry"},{"key":"14030184_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.nbd.2004.08.002","volume":"17","author":"SS Hebert","year":"2004","unstructured":"Hebert SS et al. (2004) Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol. Dis. 17:260\u201372.","journal-title":"Neurobiol. Dis."},{"key":"14030184_CR8","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1101\/gad.836900","volume":"14","author":"R Kopan","year":"2000","unstructured":"Kopan R and Goate A. (2000) A common enzyme connects notch signaling and Alzheimer\u2019s disease, Genes Dev. 14:2799\u2013806.","journal-title":"Genes Dev."},{"key":"14030184_CR9","doi-asserted-by":"publisher","first-page":"24294","DOI":"10.1074\/jbc.M211161200","volume":"278","author":"T Sato","year":"2003","unstructured":"Sato T et al. (2003) Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein. J. Biol. Chem. 278:24294\u2013301.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.embor.7400897","volume":"8","author":"B Strooper De","year":"2007","unstructured":"De Strooper B. (2007) Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep. 8:141\u20136.","journal-title":"EMBO Rep."},{"key":"14030184_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.nbd.2004.04.018","volume":"17","author":"S Hecimovic","year":"2004","unstructured":"Hecimovic S, Wang J, Dolios G, Martinez M, Wang R, and Goate AM. (2004) Mutations in APP have independent effects on Abeta and CT-Fgamma generation. Neurobiol. Dis. 17:205\u201318.","journal-title":"Neurobiol. Dis."},{"key":"14030184_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0896-6273(00)80998-8","volume":"20","author":"JA Davis","year":"1998","unstructured":"Davis JA et al. (1998) An Alzheimer\u2019s disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron. 20:603\u20139.","journal-title":"Neuron"},{"key":"14030184_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/humu.20336","volume":"27","author":"S Kumar-Singh","year":"2006","unstructured":"Kumar-Singh S et al. (2006) Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum. Mutat. 27:686\u201395.","journal-title":"Hum. Mutat."},{"key":"14030184_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/35014735","volume":"405","author":"C Russo","year":"2000","unstructured":"Russo C et al. (2000) Presenilin-1 mutations in Alzheimer\u2019s disease. Nature. 405:531\u20132.","journal-title":"Nature"},{"key":"14030184_CR15","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1021\/bi0508237","volume":"44","author":"L Miravalle","year":"2005","unstructured":"Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, and Vidal R. (2005) Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry. 44:10810\u201321.","journal-title":"Biochemistry"},{"key":"14030184_CR16","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.1523\/JNEUROSCI.1247-05.2005","volume":"25","author":"CA Saura","year":"2005","unstructured":"Saura CA et al. (2005) Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J. Neurosci. 25:6755\u201364.","journal-title":"J. Neurosci."},{"key":"14030184_CR17","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.1021\/bi051213+","volume":"44","author":"C Esh","year":"2005","unstructured":"Esh C et al. (2005) Altered APP processing in PDAPP (Val717\u2192Phe) transgenic mice yields extended-length Abeta peptides. Biochemistry. 44:13807\u201319.","journal-title":"Biochemistry"},{"key":"14030184_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1471-4159.2003.01668.x","volume":"85","author":"G Bergh Van den","year":"2003","unstructured":"Van den Bergh G, Clerens S, Cnops L, Vandesande F, and Arckens L. (2003) Fluorescent two-dimensional difference gel electrophoresis and mass spectrometry identify age-related protein expression differences for the primary visual cortex of kitten and adult cat. J. Neurochem. 85:193\u2013205.","journal-title":"J. Neurochem."},{"key":"14030184_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm0498-452","volume":"4","author":"R Crook","year":"1998","unstructured":"Crook R et al. (1998) A variant of Alzheimer\u2019s disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat. Med. 4:452\u20135.","journal-title":"Nat. Med."},{"key":"14030184_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-002-0536-6","volume":"104","author":"M Takao","year":"2002","unstructured":"Takao M et al. (2002) A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol. 104:155\u2013170.","journal-title":"Acta Neuropathol."},{"key":"14030184_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/jnen\/60.12.1137","volume":"60","author":"M Takao","year":"2001","unstructured":"Takao M et al. (2001) Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J. Neuropathol. Exp. Neurol. 60:1137\u201352.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"14030184_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/jnen\/63.3.199","volume":"63","author":"G Marcon","year":"2004","unstructured":"Marcon G et al. (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J. Neuropathol. Exp. Neurol. 63:199\u2013209.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"14030184_CR23","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/S0002-9440(10)64688-3","volume":"158","author":"DM Mann","year":"2001","unstructured":"Mann DM, Pickering-Brown SM, Takeuchi A, and Iwatsubo T. (2001) Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer\u2019s disease. Am. J. Pathol. 158:2165\u201375.","journal-title":"Am. J. Pathol."},{"key":"14030184_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","volume":"92","author":"ES Walker","year":"2005","unstructured":"Walker ES, Martinez M, Brunkan AL, and Goate A. (2005) Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in Abeta 42\/40 ratios. J. Neurochem. 92:294\u2013301.","journal-title":"J. Neurochem."},{"key":"14030184_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"M Bentahir","year":"2006","unstructured":"Bentahir M et al. (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J. Neurochem. 96:732\u201342.","journal-title":"J. Neurochem."},{"key":"14030184_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tig.2007.01.008","volume":"23","author":"AL Parks","year":"2007","unstructured":"Parks AL and Curtis D. (2007) Presenilin diversifies its portfolio. Trends Genet. 23:140\u201350.","journal-title":"Trends Genet."},{"key":"14030184_CR27","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1242\/dev.127.12.2593","volume":"127","author":"M Handler","year":"2000","unstructured":"Handler M, Yang X, and Shen J. (2000) Presenilin-1 regulates neuronal differentiation during neurogenesis. Development. 127:2593\u2013606.","journal-title":"Development"},{"key":"14030184_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/5526","volume":"5","author":"M Nishimura","year":"1999","unstructured":"Nishimura M et al. (1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat. Med. 5:1\u2013169.","journal-title":"Nat. Med."},{"key":"14030184_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/27208","volume":"395","author":"Z Zhang","year":"1998","unstructured":"Zhang Z et al. (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 395:698\u2013702.","journal-title":"Nature"},{"key":"14030184_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/00005072-199808000-00003","volume":"57","author":"O Berezovska","year":"1998","unstructured":"Berezovska O, Xia MQ, and Hyman BT. (1998) Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57:738\u201345.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"14030184_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6","volume":"181","author":"L Miele","year":"1999","unstructured":"Miele L and Osborne B. (1999) Arbiter of differentiation and death: Notch signaling meets apoptosis, J. Cell Physiol. 181:393\u2013409.","journal-title":"J. Cell Physiol."},{"key":"14030184_CR32","doi-asserted-by":"publisher","first-page":"30018","DOI":"10.1074\/jbc.M008268200","volume":"276","author":"O Berezovska","year":"2001","unstructured":"Berezovska O, Jack C, Deng A, Gastineau N, Rebeck GW, and Hyman BT. (2001) Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent gamma-secretase cleavage. J. Biol. Chem. 276:30018\u201323.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR33","doi-asserted-by":"publisher","first-page":"47370","DOI":"10.1074\/jbc.M308480200","volume":"278","author":"A Lleo","year":"2003","unstructured":"Lleo A, Berezovska O, Ramdya P, Fukumoto H, Raju S, Shah T, and Hyman BT. (2003) Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression. J. Biol. Chem. 278:47370\u20135.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1254\/jphs.CR0050014","volume":"97","author":"KA Chang","year":"2005","unstructured":"Chang KA and Suh YH. (2005) Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer\u2019s disease. J. Pharmacol. Sci. 97:461\u201371.","journal-title":"J. Pharmacol. Sci."},{"key":"14030184_CR35","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1523\/JNEUROSCI.16-21-06732.1996","volume":"16","author":"ML Oster-Granite","year":"1996","unstructured":"Oster-Granite ML, McPhie DL, Greenan J, and Neve RL. (1996) Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16:6732\u201341.","journal-title":"J. Neurosci."},{"key":"14030184_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1471-4159.1998.71020875.x","volume":"71","author":"DK Song","year":"1998","unstructured":"Song DK et al. (1998) Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice. J. Neurochem. 71:875\u20138.","journal-title":"J. Neurochem."},{"key":"14030184_CR37","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","volume":"268","author":"AE Roher","year":"1993","unstructured":"Roher AE et al. (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer\u2019s disease. J. Biol. Chem. 268:3072\u201383.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR38","doi-asserted-by":"publisher","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","volume":"90","author":"AE Roher","year":"1993","unstructured":"Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, and Ball MJ. (1993) beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90:10836\u201340.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"14030184_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/bbrc.1997.7083","volume":"237","author":"YM Kuo","year":"1997","unstructured":"Kuo YM, Emmerling MR, Woods AS, Cotter RJ, and Roher AE. (1997) Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem. Biophys. Res. Commun. 237:188\u201391.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14030184_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuroscience.2006.08.027","volume":"143","author":"A Guntert","year":"2006","unstructured":"Guntert A, Dobeli H, and Bohrmann B. (2006) High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience. 143:461\u201375.","journal-title":"Neuroscience"},{"key":"14030184_CR41","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1016\/S0021-9258(19)78080-6","volume":"269","author":"E Gowing","year":"1994","unstructured":"Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, and Ball MJ. (1994) Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269:10987\u201390.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR42","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","volume":"271","author":"YM Kuo","year":"1996","unstructured":"Kuo YM et al. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem. 271:4077\u201381.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR43","doi-asserted-by":"publisher","first-page":"20631","DOI":"10.1074\/jbc.271.34.20631","volume":"271","author":"AE Roher","year":"1996","unstructured":"Roher AE et al. (1996) Morphology and toxicity of Abeta-(1\u201342) dimer derived from neuritic and vascular amyloid deposits of Alzheimer\u2019s disease. J. Biol. Chem. 271:20631\u20135.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR44","doi-asserted-by":"publisher","first-page":"12991","DOI":"10.1074\/jbc.M007859200","volume":"276","author":"YM Kuo","year":"2001","unstructured":"Kuo YM et al. (2001) Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer\u2019s disease brains. J. Biol. Chem. 276:12991\u20138.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR45","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1021\/bi015685+","volume":"41","author":"W Kalback","year":"2002","unstructured":"Kalback W et al. (2002) APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer\u2019s disease senile plaques. Biochemistry. 41:922\u20138.","journal-title":"Biochemistry"},{"key":"14030184_CR46","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1074\/jbc.M311380200","volume":"279","author":"AE Roher","year":"2004","unstructured":"Roher AE et al. (2004) The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates. J. Biol. Chem. 279:5829\u201336.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR47","doi-asserted-by":"publisher","first-page":"10317","DOI":"10.1021\/bi700951u","volume":"46","author":"GD Vickle Van","year":"2007","unstructured":"Van Vickle GD et al. (2007) TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry. 46:10317\u201327.","journal-title":"Biochemistry"},{"key":"14030184_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","volume":"25","author":"Y Qi-Takahara","year":"2005","unstructured":"Qi-Takahara Y et al. (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J. Neurosci. 25:436\u201345.","journal-title":"J. Neurosci."},{"key":"14030184_CR49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","volume":"156","author":"YM Kuo","year":"2000","unstructured":"Kuo YM et al. (2000) Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am. J. Pathol. 156:797\u2013805.","journal-title":"Am. J. Pathol."},{"key":"14030184_CR50","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.200410090","volume":"167","author":"C Kaether","year":"2004","unstructured":"Kaether C and Haass C. (2004) A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J. Cell Biol. 167:809\u201312.","journal-title":"J. Cell Biol."},{"key":"14030184_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/09687860500496417","volume":"23","author":"JM Cordy","year":"2006","unstructured":"Cordy JM, Hooper NM, and Turner AJ. (2006) The involvement of lipid rafts in Alzheimer\u2019s disease. Mol. Membr. Biol. 23:111\u201322.","journal-title":"Mol. Membr. Biol."},{"key":"14030184_CR52","doi-asserted-by":"publisher","first-page":"44945","DOI":"10.1074\/jbc.M407986200","volume":"279","author":"KS Vetrivel","year":"2004","unstructured":"Vetrivel KS et al. (2004) Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279:44945\u201354.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1083\/jcb.200207113","volume":"160","author":"R Ehehalt","year":"2003","unstructured":"Ehehalt R, Keller P, Haass C, Thiele C, and Simons K. (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160:113\u201323.","journal-title":"J. Cell Biol."},{"key":"14030184_CR54","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","volume":"24","author":"T Kawarabayashi","year":"2004","unstructured":"Kawarabayashi T et al. (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer\u2019s disease. J. Neurosci. 24:3801\u20139.","journal-title":"J. Neurosci."},{"key":"14030184_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1471-4159.2005.03528.x","volume":"96","author":"MT Lai","year":"2006","unstructured":"Lai MT et al. (2006) A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage. J. Neurochem. 96:118\u201325.","journal-title":"J. Neurochem."},{"key":"14030184_CR56","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.1073\/pnas.0503181102","volume":"102","author":"VT Marchesi","year":"2005","unstructured":"Marchesi VT. (2005) An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U. S. A. 102:9093\u20138.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"14030184_CR57","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0959-440X(03)00102-7","volume":"13","author":"AR Curran","year":"2003","unstructured":"Curran AR and Engelman DM. (2003) Sequence motifs, polar interactions and conformational changes in helical membrane proteins. Curr. Opin. Struct. Biol. 13:412\u20137.","journal-title":"Curr. Opin. Struct. Biol."},{"key":"14030184_CR58","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0197-4580(02)00018-0","volume":"23","author":"WG Wood","year":"2002","unstructured":"Wood WG, Schroeder F, Igbavboa U, Avdulov NA, and Chochina SV. (2002) Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol. Aging. 23:685\u201394.","journal-title":"Neurobiol. Aging."},{"issue":"Suppl 1","key":"14030184_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2005.09.013","volume":"26","author":"S Yehuda","year":"2005","unstructured":"Yehuda S, Rabinovitz S, and Mostofsky DI. (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol. Aging. 26 Suppl 1:98\u2013102.","journal-title":"Neurobiol. Aging."},{"key":"14030184_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.200505082","volume":"171","author":"WH Yu","year":"2005","unstructured":"Yu WH et al. (2005) Macroautophagy\u2014a novel Beta-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease. J. Cell Biol. 171:87\u201398.","journal-title":"J. Cell Biol."},{"key":"14030184_CR61","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/01.STR.0000257802.82826.a7","volume":"38","author":"DE Bredesen","year":"2007","unstructured":"Bredesen DE. (2007) Key note lecture: toward a mechanistic taxonomy for cell death programs. Stroke. 38:652\u2013660.","journal-title":"Stroke"},{"issue":"Suppl 2","key":"14030184_CR62","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.cdd.4401777","volume":"12","author":"Y Tsujimoto","year":"2005","unstructured":"Tsujimoto Y and Shimizu S. (2005) Another way to die: autophagic programmed cell death. Cell Death. Differ. 12Suppl 2:1528\u201334.","journal-title":"Cell Death. Differ."},{"key":"14030184_CR63","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, et al. (2001) Metabolic regulation of brain Abeta by neprilysin. Science. 292:1550\u20132.","journal-title":"Science"},{"key":"14030184_CR64","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid betaprotein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U. S. A. 100:4162\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"14030184_CR65","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1073\/pnas.1031520100","volume":"100","author":"BC Miller","year":"2003","unstructured":"Miller BC et al. (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc. Natl. Acad. Sci. U. S. A. 100:6221\u20136.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"14030184_CR66","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/jmbi.1999.3492","volume":"296","author":"C Oefner","year":"2000","unstructured":"Oefner C, D\u2019Arcy A, Hennig M, Winkler FK, and Dale GE. (2000) Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J. Mol. Biol. 296:341\u20139.","journal-title":"J. Mol. Biol."},{"key":"14030184_CR67","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nature05143","volume":"443","author":"Y Shen","year":"2006","unstructured":"Shen Y, Joachimiak A, Rosner MR, and Tang WJ. (2006) Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature. 443:870\u20134.","journal-title":"Nature"},{"key":"14030184_CR68","doi-asserted-by":"publisher","first-page":"23221","DOI":"10.1074\/jbc.M300276200","volume":"278","author":"L Morelli","year":"2003","unstructured":"Morelli L et al. (2003) Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J. Biol. Chem. 278:23221\u20136.","journal-title":"J. Biol. Chem."},{"key":"14030184_CR69","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbrc.2005.05.020","volume":"332","author":"L Morelli","year":"2005","unstructured":"Morelli L et al. (2005) Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia. Biochem. Biophys. Res. Commun. 332:808\u201316.","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/2007-00094.VanVickle.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T10:38:19Z","timestamp":1663238299000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/2007-00094.VanVickle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":69,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["14030184"],"URL":"https:\/\/doi.org\/10.2119\/2007-00094.vanvickle","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}